WHO Pharmaceuticals Newsletter 1998, No. 09&10
(1998; 23 pages)
Índice de contenido
Cerrar esta carpetaRegulatory decisions
Ver el documentoAlbumin (human) B batches withdrawn: increase in aluminium level: Austria
Ver el documentoAstemizole - warning concerning arrhythmias: Brazil
Ver el documentoChlormezanone - withdrawn: Zimbabwe
Ver el documentoChlorzoxazone - warning: hepatotoxicity: Chile
Ver el documentoCidofovir - adverse reactions: nephrotoxicity, uveitis/iritis and hearing loss: Gilead Sciences, USA
Ver el documentoFenfluramine and dexfenfluramine - temporary suspension: Brazil
Ver el documentoFenfluramine and dexfenfluramine - warning concerning adverse reactions: Chile
Ver el documentoIonic contrast media - notice of withdrawal: Germany
Ver el documentoLaxatives containing aloe, bisacodyl, cascara sagrada and senna - proposed reclassification: USA
Ver el documentoMeloxicam - data sheet revised: gastrointestinal and skin reactions: UK
Ver el documentoMetamizole sodium - withdrawn due to agranulocytosis: Zimbabwe
Ver el documentoMibefradil - suspended: Germany
Ver el documentoNifedipine - re-approved in myocardial infarction: New Zealand
Ver el documentoPsorial ointment - sales prohibited: undeclared cortisone ingredients: Sweden
Ver el documentoPsorigon cream & lotion - withdrawn: undeclared cortisone ingredients: Germany, USA
Ver el documentoTiclopidine - revised data sheet: thrombotic thrombocytopenic purpura: Roche, USA
Ver el documentoTroglitazone - revised instructions for use: Parke-Davis, USA
Ver el documentoVitamin A and betacarotene - labelling claim prohibited: USA
Abrir esta carpeta y ver su contenidoDrug surveillance
Abrir esta carpeta y ver su contenidoNew developments
Abrir esta carpeta y ver su contenidoMedical devices
Abrir esta carpeta y ver su contenidoGeneral information
Abrir esta carpeta y ver su contenidoMedication errors
Abrir esta carpeta y ver su contenidoVeterinary medicine
 

Laxatives containing aloe, bisacodyl, cascara sagrada and senna - proposed reclassification: USA

United States of America. In the context of its review of over-the-counter laxative ingredients, the Food and Drug Administration has proposed to reclassify the stimulant laxative ingredients aloe, bisacodyl, cascara sagrada and senna (including sennosides) from Category I (generally recognized as safe and effective) to Category III (more data needed).

The agency reviewed available data concerning these products, and concluded that carcinogenicity data are insufficient.

The full text is available on request.

[See also Pharmaceuticals Newsletter Nos. 5&6, May & June, 1&2, January & February 1998, Nos 11&12, November & December 1997, DRS Information Exchange Alert No. 65 of 7 October 1997]

Reference: Federal Register 63(118): 33592-33595 (1998).

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013